Q3 2025 · 13F-HR
Knott David M Jrholdings as filed
Filed 2025-11-12 · accession 0001104659-25-110124
$248.0M
Reported value
88
Positions
2025-09-30
Period end
The Brief · Knott David M Jr · Q3 2025
AI · grounded in 13F
Knott David M Jr established a new position in Calumet, Inc. CLMT valued at $51.6M. The fund also initiated new stakes in Apollo Global Management, Inc. APO for $30M and Alphabet Inc-Cl C GOOG for $27.3M. Additional new positions include the Janus Henderson AAA CLO ETF JAAA and Darling Ingredients Inc. DAR.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 131428104 | CLMT | Calumet, Inc. | $51.6M | 20.8% | 2,825,231 | Common | SOLE |
| 03769M106 | APO | Apollo Global Management, Inc. | $30.0M | 12.1% | 225,000 | Common | SOLE |
| 02079K107 | GOOG | Alphabet Inc-Cl C | $27.3M | 11.0% | 112,220 | Common | SOLE |
| 47103U845 | JAAA | Janus Henderson AAA CLO ETF | $22.2M | 8.96% | 437,754 | Common | SOLE |
| 237266101 | DAR | Darling Ingredients Inc. | $9.3M | 3.73% | 300,000 | CALL | SOLE |
| 98422E103 | XERS | Xeris Biopharma Holdings, Inc. | $8.3M | 3.33% | 1,015,000 | Common | SOLE |
| 87164F105 | SNDX | Syndax Pharmaceutical, Inc. | $6.6M | 2.66% | 428,000 | Common | SOLE |
| 46625H100 | JPM | JPMorgan Chase & Co. | $6.4M | 2.59% | 20,374 | Common | SOLE |
| 89422G107 | TVTX | Travere Therapeutics, Inc. | $6.2M | 2.51% | 260,000 | Common | SOLE |
| G29687103 | AVDL | Avadel Pharmaceuticals plc | $5.5M | 2.24% | 363,000 | Common | SOLE |
| 74366E102 | PTGX | Protagonist Therapeutics, Inc | $5.5M | 2.22% | 83,000 | Common | SOLE |
| 10806X102 | BBIO | Bridgebio Pharma, Inc. | $4.4M | 1.78% | 85,000 | Common | SOLE |
| 256086109 | DCGO | DocGo, Inc. | $4.2M | 1.68% | 3,070,850 | Common | SOLE |
| 925050106 | VRNA | Verona Pharma PLC. | $4.1M | 1.65% | 38,355 | Common | SOLE |
| 52635N103 | LENZ | LENZ Therapeutics, Inc. | $3.8M | 1.54% | 82,000 | Common | SOLE |
| 14888U101 | CPRX | Catalyst Pharmaceuticals, Inc. | $3.7M | 1.50% | 189,000 | Common | SOLE |
| 76200L309 | RZLT | Rezolute, Inc. | $2.6M | 1.04% | 275,000 | Common | SOLE |
| 92790C104 | VRDN | Viridian Therapeutics, Inc. | $2.5M | 1.01% | 116,574 | Common | SOLE |
| 126408103 | CSX | CSX Corporation | $2.5M | 1.00% | 70,000 | Common | SOLE |
| 53635D202 | LQDA | Liquidia Corporation | $2.5M | 0.99% | 107,783 | Common | SOLE |
| 03940c100 | — | Arcellx Inc | $2.1M | 0.85% | 25,700 | Common | SOLE |
| 717081103 | PFE | Pfizer Inc. | $1.9M | 0.77% | 74,537 | Common | SOLE |
| 01881G106 | AB | AllianceBernstein Holding L.P. | $1.8M | 0.74% | 48,000 | Common | SOLE |
| 04963C209 | ATRC | AtriCure, Inc. | $1.7M | 0.68% | 48,000 | Common | SOLE |
| 23282W605 | CYTK | Cytokinetics, Incorporated | $1.6M | 0.66% | 30,000 | Common | SOLE |
| 90400D108 | RARE | Ultragenyx Pharmaceutical Inc. | $1.6M | 0.63% | 52,000 | Common | SOLE |
| 74006W207 | PRAX | Praxis Precision Medicines, Inc. | $1.5M | 0.60% | 28,000 | Common | SOLE |
| 03969F109 | RCUS | Arcus Biosciences, Inc. | $1.3M | 0.52% | 95,200 | Common | SOLE |
| 478160104 | JNJ | Johnson & Johnson | $1.3M | 0.52% | 6,922 | Common | SOLE |
| 81752T528 | CLOZ | The Panagram BBB-B CLO | $1.3M | 0.52% | 47,807 | Common | SOLE |
| 110122108 | BMY | Bristol-Myers Squibb Company | $1.2M | 0.49% | 27,000 | Common | SOLE |
| 00287Y109 | ABBV | AbbVie Inc. | $1.2M | 0.47% | 5,037 | Common | SOLE |
| 878972108 | TECX | Tectonic Therapeutic, Inc. | $1.2M | 0.47% | 74,000 | Common | SOLE |
| 78377T107 | RHP | Ryman Hospitality Properties, Inc. | $1.1M | 0.43% | 12,000 | Common | SOLE |
| 83422E204 | SLDB | Solid Bioscience Inc. | $1.0M | 0.40% | 162,440 | Common | SOLE |
| 23954D109 | DAWNGBX | Day One Biopharmaceuticals, Inc. | $920,025 | 0.37% | 130,500 | Common | SOLE |
| 558868105 | MDGL | Madrigal Pharmaaceuticals, Inc. | $917,320 | 0.37% | 2,000 | Common | SOLE |
| 594918104 | MSFT | Microsoft Corporation | $828,720 | 0.33% | 1,600 | Common | SOLE |
| 23256X407 | HELP | Cybin Inc | $826,025 | 0.33% | 140,242 | Common | SOLE |
| 92337R101 | VERA | Vera Therapeutics, Inc. | $755,560 | 0.30% | 26,000 | Common | SOLE |
| 22052L104 | CTVA | Corteva, Inc. | $747,379 | 0.30% | 11,051 | Common | SOLE |
| 494368103 | KMB | Kimberly-Clark Corporation | $746,040 | 0.30% | 6,000 | Common | SOLE |
| 26614N102 | DD | DuPont de Nemours, Inc. | $733,662 | 0.30% | 9,418 | Common | SOLE |
| Y95308105 | WVE | Wave Life Science Ltd. | $658,800 | 0.27% | 90,000 | Common | SOLE |
| 464287556 | IBB | iShares Biotechnology ETF | $649,665 | 0.26% | 4,500 | Common | SOLE |
| 037833100 | AAPL | Apple Inc. | $635,047 | 0.26% | 2,494 | Common | SOLE |
| 589492107 | MREO | Mereo BioPharm Group PLC | $618,694 | 0.25% | 300,337 | Common | SOLE |
| 459200101 | IBM | International Business Machines | $604,387 | 0.24% | 2,142 | Common | SOLE |
| 50127T109 | KURA | Kura Oncology, Inc. | $595,623 | 0.24% | 67,302 | Common | SOLE |
| G01767105 | ALKS | Alkermes PLC | $579,000 | 0.23% | 19,300 | Common | SOLE |
| 136385101 | CNQ | Canadian Natural Resources Limited | $536,928 | 0.22% | 16,800 | Common | SOLE |
| 78464A870 | XBI | SPDR S&P Biotech ETF | $501,000 | 0.20% | 5,000 | Common | SOLE |
| 609207105 | MDLZ | Mondelez International Inc. | $499,720 | 0.20% | 8,000 | Common | SOLE |
| 68572M106 | OBIO | Orchestra Biomed Holdings, Inc. | $483,600 | 0.20% | 195,000 | Common | SOLE |
| 31189P102 | FATE | Fate Therapeutics, Inc. | $459,900 | 0.19% | 365,000 | Common | SOLE |
| 98420N105 | XENE | Xenon Pharmaceuticals Inc. | $440,124 | 0.18% | 10,962 | Common | SOLE |
| 471871202 | JSPR | Jasper Therapeutics, Inc. | $407,906 | 0.16% | 171,389 | Common | SOLE |
| 80706P103 | SRRK | Scholar Rock Holding Corporation | $335,160 | 0.14% | 9,000 | Common | SOLE |
| 09062X103 | BIIB | Biogen Inc. | $280,160 | 0.11% | 2,000 | Common | SOLE |
| 09058V103 | BCRX | BioCryst Pharmaceuticals, Inc. | $247,206 | 0.10% | 32,570 | Common | SOLE |
| 67066G104 | NVDA | Nvidia Corp | $238,816 | 0.10% | 1,280 | Common | SOLE |
| 11135F101 | AVGO | Broadcom, Inc. | $234,236 | 0.09% | 710 | Common | SOLE |
| 532457108 | LLY | Eli Lilly & Co. | $228,900 | 0.09% | 300 | Common | SOLE |
| 171126204 | PTHS | Pelthos Therapeutics, Inc. | $171,136 | 0.07% | 6,112 | Common | SOLE |
| N90064101 | QURE | uniQure N.V. | $116,740 | 0.05% | 2,000 | Common | SOLE |
| 52472M101 | LEGH | Legacy Housing Corporation | $110,040 | 0.04% | 4,000 | Common | SOLE |
| 00534A102 | IVVD | Invivyd, Inc. | $110,000 | 0.04% | 100,000 | Common | SOLE |
| 464287499 | IWR | iShares Russell Mid-Cap Growth | $98,975 | 0.04% | 695 | Common | SOLE |
| 27627N105 | EBC | Eastern Bankshares Inc | $90,750 | 0.04% | 5,000 | Common | SOLE |
| 911363109 | URI | United Rental, Inc. | $74,463 | 0.03% | 78 | Common | SOLE |
| 74762E102 | QURE | Quanta Services, Inc. | $72,938 | 0.03% | 176 | Common | SOLE |
| 02079k305 | — | Alphabet Inc CL A | $72,930 | 0.03% | 300 | Common | SOLE |
| 89151E109 | TTEN | Total Energies | $71,628 | 0.03% | 1,200 | Common | SOLE |
| 023135106 | AMZN | Amazon.com Inc. | $65,871 | 0.03% | 300 | Common | SOLE |
| G4863A108 | BRSL | Brightstar Lottery PLC | $43,125 | 0.02% | 2,500 | Common | SOLE |
| 302635107 | FSK | FS KKR Capital Corp. | $42,924 | 0.02% | 2,875 | Common | SOLE |
| 09260d107 | — | Blackstone Group LP | $35,878 | 0.01% | 210 | Common | SOLE |
| 235851102 | DHR | Danaher Corporation | $35,687 | 0.01% | 180 | Common | SOLE |
| 260557103 | DOW | Dow Inc. | $27,654 | 0.01% | 1,206 | Common | SOLE |
| 674599105 | OXY | Occidential Pertro Wts exp. 8/3/27 | $26,428 | 0.01% | 663 | Common | SOLE |
| 883556102 | TMO | Thermo Fisher Scientific, Inc. | $21,826 | 0.01% | 45 | Common | SOLE |
| 00208D408 | AETUF | Arc Resources Ltd. | $20,239 | 0.01% | 1,110 | Common | SOLE |
| 91324p102 | — | United Healthcare Corp. | $19,682 | 0.01% | 57 | Common | SOLE |
| 79466L302 | CRM | Salesforce, Inc. | $18,249 | 0.01% | 77 | Common | SOLE |
| 50155Q100 | KD | Kyndryl Holdings Inc. | $12,853 | 0.01% | 428 | Common | SOLE |
| 85571B105 | STWD | Starwood Property Trust Inc. | $7,748 | 0.00% | 400 | Common | SOLE |
| 36266G107 | GEHC | GE HealthCare Technologies Inc | $3,755 | 0.00% | 50 | Common | SOLE |
| 929740108 | WAB | Wabtec Corporation | $1,203 | 0.00% | 6 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.